National source record
Original product, substance, identifiers and source attributes.
MEDIMAPPER API
Bring national source records, shared substance identities and normalised product attributes into your own systems. Match results stay transparent, so internal search, master-data and research workflows can use the same evidence.
LOCAL RECORDS AND COMPARABLE LAYERS
The API preserves each national record, connects the active substance to a shared identity and calculates product relationships without collapsing products into one global item.
ONE SUBSCRIPTION, THREE ACCESS CHANNELS
Regional permissions, data-licensing terms and applicable fair-use limits apply across every access channel.
Search, compare and analyse medicine records in the Medimapper interface.
Bring national records, shared identities, normalised attributes and match results into your own systems.
Allow approved AI assistants and agents to query licensed Medimapper data through a controlled access layer.
CONCEPTUAL DATA MODEL
Original product, substance, identifiers and source attributes.
An international identity connected through maintained evidence.
Comparable strength and pharmaceutical form alongside the original values.
Pack size, configuration and commercial identifiers where available.
A dynamic relationship stating which level the available attributes support.
CONCEPTUAL JSON
This illustrative fragment explains the data model only. It is not an endpoint contract or production payload.
{
"sourceRecord": {
"country": "FR",
"productName": "Doliprane 0.5 g",
"strength": "0.5 g",
"form": "comprimé",
"pack": "16 comprimés"
},
"normalised": {
"substance": "Paracetamol",
"strength": "500 mg",
"form": "tablet",
"packSize": 16
},
"comparison": {
"substanceMatch": true,
"presentationMatch": true,
"packMatch": false
}
}COMMON API WORKFLOWS
Start with a local product, code or substance and retrieve related records in selected countries.
Connect internal records to shared substance identities, normalised attributes and international reference identifiers.
Compare national product presence, manufacturers, strengths, forms and packs.
Preserve source fields and show which attributes support each comparison result.
Allow authorised assistants and agents to query licensed data through the Medimapper MCP layer.
FROM EVALUATION TO PRODUCTION ACCESS
Tell us which products, regions, data layers and internal decisions the integration must support.
Confirm field availability, source depth, update information and material limitations for the required markets.
Review real sample records, match semantics and the intended handling of source and normalised values.
Confirm regions, authentication, fair-use limits, permitted use, support and data-licensing terms.
Implement against the production API documentation and versioned response contract.
WHAT TECHNICAL TEAMS NEED TO REVIEW
| Information | Availability |
|---|---|
| API documentation | Available on request |
| Authentication and access model | Available on request |
| Versioning and change policy | Available on request |
| Pagination and rate limits | Available on request |
| Data refresh and update commitments | Available on request |
| Permitted use and redistribution terms | Available on request |
| Security and privacy brief | Available on request |
| Onboarding and support model | Available on request |
DATA RESPONSIBILITY
Your organisation remains responsible for validating results for the intended use and for every clinical, regulatory, quality, legal and commercial decision made with the data.
START WITH YOUR PRODUCTS